Newsroom

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of Class A common stock of Snowflake Inc. (NYSE: SNOW) between June 27, 2023 and the close of the market on February 28, 2024 (4:00 p.m. ET). Snowflake describes itself as a “software company that provides cloud data storage that enables customers to consolidate data onto data-driven applications and share data for the purpose of running analytics and other proc...

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Zynex, Inc. (NASDAQ: ZYKIQ) securities between February 25, 2021 and December 15, 2025. Zynex is a medical device manufacturer that produces and markets electrotherapy devices for use in pain management, physical rehabilitation, neurological diagnosis, and cardiac monitoring. For more information, submit a form, email attorney Aaron Dumas, Jr....

BÂLE, Suisse--(BUSINESS WIRE)--Ascensia Diabetes Care, une société internationale spécialisée dans le traitement du diabète et une filiale de PHC Holdings Corporation (TSE : 6523), a annoncé aujourd’hui la nomination de Peter Bodlund au poste de président-directeur général, à compter du 1er avril 2026. Il succède à Koichiro Sato, qui continuera d’exercer ses fonctions de directeur de l’exploitation et de responsable de l’activité Gestion du diabète de PHC Group. M. Bodlund a occupé divers poste...

BASEL, Schweiz--(BUSINESS WIRE)--Ascensia Diabetes Care, ein weltweit tätiges Unternehmen für Diabetesversorgung und eine Tochtergesellschaft der PHC Holdings Corporation (TSE: 6523), teilte heute mit, dass Peter Bodlund mit Wirkung zum 1. April 2026 zum President und CEO ernannt wurde. Er tritt die Nachfolge von Koichiro Sato an, der seine Funktionen als Chief Operating Officer der PHC Group und Leiter des Geschäftsbereichs Diabetes Management weiterhin ausüben wird. Peter Bodlund war in leite...

BOSTON & HONG KONG--(BUSINESS WIRE)--KED Global Awards Press Release...

LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,* today announced positive 12-month interim efficacy and tolerability data from the phase IIb EMBRACE study.1 In adults living with HIV on stable therapy, a regimen of lotivibart (N6LS), a broadly neutralising antibody, administered every four months combined with monthly intramuscular (IM) long-acting cabotegravir (CAB LA), maintained viral suppression in...

JUNEAU, Alaska--(BUSINESS WIRE)--The Alaska Permanent Fund Corporation’s (APFC) Board of Trustees convened its quarterly meeting on February 23 and 24, 2026, in Juneau and online. Trustees received updates on the Fund’s operations and investment activity, including presentations on asset allocation and Fixed Income. Legislative Partnership Honoring 50 Years of the Alaska Permanent Fund The 34th Alaska State Legislature's presiding officers, Senate President Gary Stevens and Speaker of the House...

LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,* today announced data from its phase 1 study of long-acting formulations of VH184, the first, third-generation integrase strand transfer inhibitor (INSTI) in development for HIV.1 Results show a single-dose injection could maintain drug levels for up to six months. In-vitro data from a separate study demonstrate improved potency and an enhanced resistance...

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Transact + CBORD partners with MyVenue to power campus card payments at athletic and special events....

SAN FRANCISCO--(BUSINESS WIRE)--Balfour Beatty recognized by AGC for their involvement in the delivery of the Caltrain Electrification project in California....